Annex A

Annals of the ICRP

Volumn 37, Issue 2-4, 2007, Pages 137-246

  ICRP, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36849041588     PISSN: 01466453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.icrp.2007.10.009     Document Type: Article

References (165)

1. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3)
2. ICRP, 1999b. Risk estimation for multifactorial diseases. ICRP Publication 83. Ann. ICRP 29 (3–4)
3. R ). ICRP Publication 92. Ann. ICRP 33 (4)
4. ICRP, 2005d. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99. Ann. ICRP 35 (4)
5. ICRP, 2006a. Assessing dose of the representative person for the purpose of radiation protection of the public and The optimisation of radiological protection: Broadening the process. ICRP Publication 101. Ann. ICRP 36 (3).
6. ICRP, 2007b. Radiological protection in medicine. ICRP Publication 105. Ann. ICRP 37 (5).
7. CERRIE, 2004. Report of the Committee Examining Radiation Risks of Internal Emitters (CERRIE). CERRIE: London October 2004, www.cerrie.org ISBN 0–85951–545-1.
8. th Symposium on Microdosimetry. Radiat. Prot. Dosim. 99 Nos. 1–4.
9. Cox, R., Edwards, A.A., 2002. Comments on the paper: Microsatellite instability in acute myelocylic leukaemia developed from A-bomb survivors and related cytogenetic data. Int. J. Radiat. Biol. 78, 443–445.
10. Ellender, M., Harrison, J.D., Edwards, A.A., et al., 2005. Direct single gene mutational events account for radiation-induced intestinal adenoma yields in Apc ( min /+) mice. Radiat. Res. 163, 552–556.
11. Goodhead, D.G., O’Neill, P., Menzel, H.G. (Eds.), 1996. Microdosimetry: An interdisciplinary approach. Proceedings of the 12th Symposium on Microdosimetry. Royal Society of Chemistry, Cambridge.
12. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3)
13. ICRP, 1998a. Genetic susceptibility to cancer. ICRP Publication 79. Ann. ICRP, 28 (1/2).
14. R ). ICRP Publication 92. Ann. ICRP 33 (4).
15. ICRP, 2005d. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99. Ann. ICRP 35 (4).
16. Izumi, S., Suyama, A., Koyama, K., 2003a. Radiation-related mortality among offspring of atomic bomb survivors after a half-century of follow-up. Int. J. Cancer 107, 291–297.
17. Izumi, S. Koyama, K., Soda, M., et al, 2003b. Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs. Br. J. Cancer 89, 1709–1713.
18. Little, J.B., 2003. Genomic instability and bystander effects: a historical perspective. Oncogene 22, 6978–6987.
19. Lohrer, H.D., Braselmann, H., Richter, H.E., et al., 2001. Instability of microsatellites in radiation-associated thyroid tumours with short latency periods. Int. J. Radiat. Biol. 77, 891–899.
20. Morgan, W.F., 2003. Non-targeted and delayed effects of exposure to ionizing radiation: I Radiation-induced genomic instability and bystander effects in vitro. Radiat. Res. 159, 567–580.
21. Mothersill, C., Seymour, C., 2001. Radiation-induced bystander effects: Past history and future directions. Radiat. Res. 155, 759–767.
22. Nakanishi, M., Tanaka, K., Takahashi, T., et al., 2001. Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors. Int. J. Radiat. Biol. 77: 687–694 and Comments (2002), Int. J. Radiat. Biol. 78, 441–445.
23. NAS/NRC, 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Board on Radiation Effects Research. National Research Council of the National Academies, Washington, D.C.
24. NCRP, 2001. Evaluation of the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP Report No. 36. National Council on Radiation Protection and Measurements, Bethesda, MD.
25. Tawn, E.J., Whitehouse, C.A., Tarone, R.E., 2004. FISH Chromosome analysis of retired radiation workers from the Sellafield nuclear facility. Radiat. Res. 162, 249–256.
26. Thacker, J., Nygaard, O.F., Sinclair, W.K., et al., 1992. Radiation induced mutation in mammalian cells at low doses and dose rates. Advances in Radiation Biology, Vol. 16. Academic Press Inc, New York, NY, pp. 77–124.
27. Tucker, J.D.; Tawn, E.J., Holdsworth, D., et al.,1997. Biological dosimetry of radiation workers at the Sellafield nuclear facility. Radiat. Res. 148, 216–226.
28. UNSCEAR, 1993. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1993 Report to the General Assembly with Scientific Annexes, United Nations, New York.
29. UNSCEAR, 1994. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1994 Report to the General Assembly with Scientific Annexes, United Nations, New York.
30. UNSCEAR, 2000. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. Vol. II Effects. 2000 Report to the General Assembly with Scientific Annexes, United Nations, New York.
31. UNSCEAR, 2001. United Nations Scientific Committee on the Effects of Atomic Radiation. Heritable Effects of Radiation. 2001 Report to the General Assembly with Scientific Annex, United Nations, New York.
32. AFRRI Contract Report 94-1, 1994. Analysis of chronic radiation sickness cases in the population of the Southern Urals. AFRRI, Bethesda, Maryland, USA.
33. AFRRI Contract Report 98-1, 1998. Chronic radiation sickness among Techa Riverside Residents. AFRRI, Bethesda, Maryland, USA.
34. Akleyev, A.V., Kisselyov, M.F. (Eds.), 2002. Medical-biological and ecological impacts of radioactive contamination of the Techa river. Fregat, Chelyabinsk. ISBN5-88931-026-7.
35. Akleyev, A., Veremeyeva, G.A., Silkina, L.A., et al., 1999. Long-term hemopoiesis and immunity status after chronic radiation exposure of red bone marrow in humans. Central European Journal of Occ. and Env. Medicine 5, 113–129.
36. Dörr, W., Hendry, J.H., 2001. Consequential late effects in normal tissues. Radiother. Oncol. 61, 223–231.
37. Edwards, A.A. and Lloyd, D.C., 1996. Risk from deterministic effects of ionising radiation. Doc. NRPB Vol. 7 No.3.
38. A.K. Guskova I.A. Gusev N.D. Okladnikova Russian concepts of chronic radiation disease in man Br. J. Radiol. Supp. 26 2002 19 23
39. Hall, P., Granath, F., Lundell, M., et al., 1999. Lenticular opacities in individuals exposed to ionising radiation in infancy. Radiat. Res. 152, 190–195
40. J.H. Hendry Biological response modifiers and normal tissue injury after irradiation Seminars in Radiation Oncology 4 1994 123 132
41. J.H. Hendry H.D. Thames Fractionation in Radiotherapy 1987 Taylor and Francis London
42. ICRP, 1984. Non-stochastic effects of irradiation. ICRP Publication 41. Ann. ICRP 14 (3)
43. ICRP, 1989b. RBE for deterministic effects. ICRP Publication 58. Ann. ICRP 20 (4)
44. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3)
45. ICRP, 2003a. Biological effects after prenatal irradiation (embryo and fetus). ICRP Publication 90. Ann. ICRP 33 (1/2)
46. Joiner, M.C., Marples, B., Lambin, P., et al., 2001. Low-dose hypersensitivity: current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 49, 379–389.
47. Jung, H., Beck-Bornholdt, H.P., Svoboda, V., et al., 2001. Quantification of late complications after radiation therapy. Radiother. Oncol. 61, 233–246.
48. Lefaix, J.L., Delanian, S., Leplat, J.J., et al., 1996. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study. Int. J. Radiat. Oncol. Biol. Phys. 35, 305–312.
49. Michalowski, A., 1981. Effects of radiation on normal tissues: hypothetical mechanisms and limitations of in situ assays of clonogenicity. Radiat. Environ. Biophys. 19, 157–172.
50. Minamoto, A., Taniguchi, H., Yoshitani, N., et al., 2004. Cataracts in atomic bomb survivors. Int. J. Radiat. Biol. 80, 339–345.
51. NCRP, 1974. Radiological factors affecting decision-making in a nuclear attack. Report No. 42. National Council on Radiation Protection and Measurements, Bethesda, MD.
52. NCRP, 1989. Radiation protection for medical and allied health personnel. Report No. 105. National Council on Radiation Protection and Measurements, Bethesda, MD.
53. NUREG, 1997. Probabilistic accident consequence uncertainty analysis – Early health effects uncertainty assessment. CR-6545/ EUR 16775. US Nuclear Regulatory Commission, Washington DC, USA, and Commission of the European Communities, Brussels, Belgium.
54. Okunieff, P., Mester, M., Wang, J., et al., 1998. In-vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat. Res. 150, 204– 211.
55. M. Otake W.J. Schull Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system Radiat. Res. 121 1990 3 31
56. Rubin, P., Finklestein, J.N., Williams, J.P., 1998. Paradigm shifts in the radiation pathophysiology of late effects in normal tissues: molecular vs classical concepts. In: Tobias, J.S. and Thomas, P.R.M. (Eds) Current Radiation Oncology Vol 3. Arnold, London.
57. Scott, B.R., 1993. Early occurring and continuing effects. In: Modification of models resulting from addition of effects of exposure to alpha-emitting nuclides. Washington, D.C., Nuclear Regulatory Commission, NUREG/CR-4214, Rev 1, Part II, Addendum 2 (LMF-136)
58. Scott, B.R., Hahn, F.F., 1989. Early occurring and continuing effects models for nuclear power plant accident consequence analysis. Low-LET radiation. Washington DC, Nuclear Regulatory Commission, NUREG/CR-4214 (SAND85-7185) Rev. 1, Part II.
59. UNSCEAR, 1988. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, Effects and Risks of Ionizing Radiation. 1988 Report to the General Assembly with Annexes, United Nations, New York.
60. van der Kogel, A.J., 2002. Radiation response and tolerance of normal tissues. In: Basic Clinical Radiobiology. Steel, G.G. (Ed). Arnold, London.
61. Wang, J., Albertson, C.M., Zheng, H., et al., 2002. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine. Thromb. Haemost. 87, 122–128.
62. Wheldon, T.E., Michalowski, A.S., Kirk, J., 1982. The effect of irradiation on function in self-renewing normal tissues with differing proliferative organisation. Br. J. Radiol. 55, 759–766.
63. Withers, H.R., Taylor, J.M., Maciejewski, B., 1988. Treatment volume and tissue tolerance. Int. J. Radiat. Oncol. Biol. Phys. 14, 751–759.
64. Cardis, E., Vrijheid, M., Blettner, M., et al., 2005. Risk of cancer after low doses of ionising radiation: retrospective cohort study in 145 countries. Br. Med. J. 331, 77–80.
65. CERRIE, 2004. Report of the Committee Examining Radiation Risks of Internal Emitters (CERRIE). CERRIE: London October 2004, www.cerrie.org ISBN 0–85951–545-1.
66. S. Darby D. Hill A. Auvinen Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies Br. Med. J. 330 2005 223 226
67. EPA, 1999. Estimating Radiogenic Cancer Risks. Environmental Protection Agency Report 402-R-00-003, Washington DC.
68. French Academies Report, 2005. La relation dose-effet et l’estimation des effets cancérogènes des faibles doses de rayonnements ionisants ( http://www.academie-sciences.fr/publications/raports/pdf/doseeffect070405gb.pdf )
69. IARC, 2000. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, Part I: X and gamma radiation and neutrons, vol. 75. IARC Press, Lyon.
70. IARC, 2001. IARC monographs on the evaluation of carcinogenic risks to humans. Ionizing radiation, Part 2: some internally deposited radionuclides, vol. 78. IARC Press, Lyon.
71. ICRP, 1991a. The biological basis for dose limitation in the skin. ICRP Publication 59. Ann. ICRP 22 (2)
72. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3)
73. ICRP, 1998a. Genetic susceptibility to cancer. ICRP Publication 79. Ann. ICRP 28 (1/2)
74. ICRP, 2003a. Biological effects after prenatal irradiation (embryo and fetus). ICRP Publication 90. Ann. ICRP 33 (1/2).
75. ICRP, 2003c. Relative biological effectiveness (RBE), quality factor (Q) and radiation weighting factor (wR). ICRP Publication 92. Ann. ICRP 33 (4)
76. ICRP, 2005d. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99. Ann. ICRP 35 (4)
77. D. Krewski J.H. Lubin J.M. Zielinski Residential radon and risk of lung cancer: a combined analysis of seven North American case-control studies Epidemiology 16 2005 137 145
78. Land, C.E., Hayakawa, N., Machado, S.G., et al., 1994. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 5, 167–76.
79. Land, C.E. and Sinclair, W.K., 1991. The relative contributions of different organ sites to the total cancer mortality associated with low-dose radiation exposure. Ann ICRP 22, 31–57.
80. Lubin, J.H., Boice, J.D. Jr, Edling, C. et al., 1995. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J. Natl Cancer. Inst. 87, 817–827.
81. Lubin, J.H., Wang, Z.Y., Boice, J.D. Jr, et al., 2004. Risk of lung cancer and residential radon in China: pooled results of two studies. Int. J. Cancer, 109, 132–7.
82. Mitchel, R.E., Jackson, J.S., McCann, R.A., et al., 1999. The adaptive response modifies latency for radiation-induced myeloid leukaemia in CBA/H mice. Radiat. Res. 152, 273–279.
83. Mitchel, R.E., Jackson, J.S., Morrison, D.P., et al., 2003. Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat. Res. 159, 320–327.
84. NAS/NRC, 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Board on Radiation Effects Research. National Research Council of the National Academies, Washington, D.C.
85. NCI/CDC, 2003. Report of the NCI-CDC Working Group to revise the 1985 NIH Radioepidemiological Tables. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, Maryland, NIH Publication No. 03–5387.
86. NCRP, 1997. Uncertainties in Fatal Cancer Risk Estimates Used in Radiation Protection. NCRP Report No. 126. National Council on Radiation Protection and Measurements, Bethesda, MD.
87. NCRP, 2001. Evaluation of the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP Report No. 36. National Council on Radiation Protection and Measurements, Bethesda, MD.
88. Parkin, D.M., Whelan, S.L., Ferlay, J., et al. (Eds.), 2002. Cancer Incidence in Five Continents Vol VIII. IARC Scientific Publications No. 155. Lyon International Agency for Research on Cancer.
89. Pierce, D.A., Sharp, G.B., and Mabuchi, K., 2003. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat. Res. 159, 511–520.
90. Pierce, D.A., Stram, D.O., and Vaeth, M., 1990. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat. Res. 123, 275–284.
91. Preston, D.L., Kusumi, S., Tomonaga, M., et al., 1994. Cancer incidence in atomic bomb survivors. Part III. Leukaemia, lymphoma and multiple myeloma, 1950–1987. Radiat. Res. 137, S68–97.
92. Preston, D.L., Mattsson, A., Holmberg, E., et al., 2002. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat. Res. 158, 220–235.
93. Preston, D.L., Shimizu, Y., Pierce, D.A., et al. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and non-cancer disease mortality 1950–1997. Radiat. Res. 160, 381–407.
94. Preston, D.L., Pierce, D.A., Shimizu, Y., et al., 2004. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377–389.
95. D.L. Preston E. Ron S. Tokuoka Solid cancer incidence in atomic bomb survivors: 1958–98 Radiat. Res. 168 2007 1 64
96. Puskin, J.S., Nelson, N.S., Nelson, C.B., 1992. Bone cancer risk estimates. Health Phys. 63, 579–580.
97. Ron, E., Lubin, J.H., Shore, R.E., et al., 1995. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141, 259–277.
98. E. Ron D.L. Preston M. Kishikawa Skin tumor risk among atomic-bomb survivors in Japan Cancer Causes Control 9 1998 393 401
99. Sharp, G.B., Mizuno, T., Cologne, J.B., et al., 2003. Hepatocellular carcinoma among atomic bomb survivors: significant interaction of radiation with hepatitis C virus infections. Int. J. Cancer 103, 531–537.
100. Thompson, D.E., Mabuchi, K., Ron, E., et al., 1994. Cancer Incidence in atomic bomb survivors. Part II: Solid tumours, 1958–1987. Radiat. Res. 137, S17–67.
101. Travis, L.B., Gospodarowicz, M., Curtis, R.E., et al., 2002. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J. Natl Cancer Inst. 94, 182–192.
102. UNSCEAR, 1993. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1993 Report to the General Assembly with Scientific Annexes, United Nations, New York.
103. UNSCEAR, 1994. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1994 Report to the General Assembly with Scientific Annexes, United Nations, New York.
104. UNSCEAR, 2000. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. Vol. II Effects. 2000 Report to the General Assembly with Scientific Annexes, United Nations, New York.
105. UNSCEAR, 2001. United Nations Scientific Committee on the Effects of Atomic Radiation. Heritable Effects of Radiation., 2001 Report to the General Assembly with Scientific Annex, United Nations, New York.
106. B.M. Aleman A.W. van den Belt-Dusebout W.J. Klokman Long-term cause-specific mortality of patients treated for Hodgkin’s disease J. Clin. Oncol. 21 2003 3431 3439
107. Early Breast Cancer Trialists’ Collaborative Group, 2000. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355, 1757–1770.
108. Hancock, S.L., Tucker, M.A. and Hoppe, R.T., 1993. Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. J. Am. Med. Assoc. 270, 1949–55.
109. Hayashi, T., Kusunoki, Y., Hakoda, M., et al., 2003. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int. J. Radiat. Biol. 79, 129–36.
110. McGale, P. and Darby, S.C., 2005. Low doses of ionizing radiation and circulatory diseases: A systematic review of the published epidemiological evidence. Radiat Res. 163, 247–257.
111. Preston, D.L., Shimizu, Y., Pierce, D.A., et al. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and non-cancer disease mortality 1950–1997. Radiat. Res. 160, 381–407.
112. UNSCEAR, 2008. Effects of Ionizing Radiation. United Nations Scientific Committee on the Effects of Atomic Radiation Report to the General Assembly with Scientific Annexes. United Nations, New York, NY.
113. C. Brewer S. Holloway P. Zawalnyski A chromosomal deletion map of human malformations Am. J. Hum. Genet. 63 1998 1153 1159
114. C.O. Carter The inheritance of pyloric stenosis Brit. Med. Bull. 17 1961 251 254
115. C.O. Carter Monogenic disorders J. Med. Genet. 14 1977 316 320
116. Cattanach, B.M., Burtenshaw, M.D., Rasberry, C., et al., 1993. Large deletions and other gross forms of chromosome imbalance compatible with viability and fertility in the mouse. Nature Genet. 3, 56–61.
117. Cattanach, B.M., Evans, E.P., Rasberry, C., et al., 1996. Incidence and distribution of radiation-induced large deletions in the mouse. In: Hagen, U., Harder, D., Jung, H. et al. (Eds). Congress Proceedings, Tenth Int. Cong. Radiat. Res., Würzburg, Germany, Vol. 2, 531–534.
118. R. Chakraborty N. Yasuda C. Denniston K. Sankaranarayanan Ionizing radiation and genetic risks. VII. The concept of mutation component and its use in risk estimation for mendelian diseases Mutat. Res. 400 1998 41 52
119. J.F. Crow C. Denniston The mutation component of genetic damage Science 212 1981 888 893
120. J.F. Crow C. Denniston Mutation in human populations H. Harris H. Hirschhorn Adv. Hum. Genet. Vol. 12 1985 Plenum Press N.Y 59 123
121. A. Czeizel K. Sankaranarayanan The load of genetic and partially genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms of years lost and years of impaired life Mutat. Res. 128 1984 73 103
122. A. Czeizel K. Sankaranarayanan A. Losonci The load of genetic and partially genetic disorders in man. II. Some selected common multifactorial diseases. Estimates of population prevalence and of detriment in terms of years lost and impaired life Mutat. Res. 196 1988 259 292
123. C. Denniston R. Chakraborty K. Sankaranarayanan Ionizing radiation and genetic risks. VIII. The concept of mutation component and its use in risk estimation for multifactorial diseases Mutat. Res. 405 1998 7 79
124. U.H. Ehling The frequency of X-ray-induced dominant mutations affecting the skeleton in mice Genetics 51 1965 723 732
125. U.H. Ehling Dominant mutations affecting the skeleton in offspring of X-irradiated male mice Genetics 54 1966 1381 1389
126. D.S. Falconer Introduction to Quantitative Genetics 1960 Oliver and Boyd Edinburgh
127. D.S. Falconer The inheritance of liability to certain diseases, estimated from the incidence among relatives Ann. Hum. Genet. (Lond) 29 1965 51 76
128. J. Favor Risk estimation based on germ cell mutations in animals Genome 31 1989 844 852
129. Green, E.L., 1968. Genetic effects of radiation on mammalian populations. Ann. Rev. Genet. 2, 87–120.
130. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3)
131. ICRP, 1998a. Genetic susceptibility to cancer. ICRP Publication 79. Ann. ICRP 28 (1/2)
132. ICRP, 1999b. Risk estimation for multifactorial diseases. ICRP Publication 83. Ann. ICRP 29 (3–4)
133. K.M. Kirk M.F. Lyon Induction of congenital abnormalities in the offspring of male mice treated with x rays at pre-meiotic and post-meiotic stages Mutat. Res. 125 1984 75 85
134. Lyon, M.F., Renshaw, R., 1988. Induction of congenital malformation in mice by parental irradiation: transmission to later generations. Mutat. Res. 198, 277–283.
135. NAS/NRC, 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Board on Radiation Effects Research. National Research Council of the National Academies, Washington, D.C.
136. T. Nomura Parental exposure to X-rays and chemicals induces heritable tumors and anomalies in mice Nature 296 1982 575 577
137. T. Nomura X-ray and chemically induced germ line mutations causing phenotypic anomalies in mice Mutat. Res. 198 1988 309 320
138. T. Nomura Male-mediated teratogenesis: ionizing radiation and ethylnitrosourea studies D.R. Mattison A.F. Olshan Male-mediated Developmental Toxicity 1994 Plenum Press New York 117 127
139. NRC, 1972. National Academy of Sciences-National Research Council, The BEIR Report. National Academy Press, Washington, D.C.
140. NRC, 1990. National Academy of Sciences-National Research Council, The BEIR V Report. National Academy Press, Washington, D.C.
141. K. Sankaranarayanan Genetic effects of ionising radiation in man Ann. ICRP 22 1991 76 94
142. K. Sankaranarayanan Ionizing radiation and genetic risks. IX. Estimates of the frequencies of mendelian diseases and spontaneous mutation rates in human populations: a 1998 perspective Mutat. Res. 411 1998 129 178
143. K. Sankaranarayanan Ionizing radiation and genetic risks. X. The potential ‘disease phenotypes’ of radiation-induced genetic damage in humans: perspectives from human molecular biology and radiation genetics Mutat. Res. 429 1999 45 83
144. K. Sankaranarayanan R. Chakraborty Ionizing radiation and genetic risks. XI. The doubling-dose estimates from the mid 1950s to the present, and the conceptual change to the use of human data on spontaneous mutation rates and mouse data on induced mutation rates for doubling-dose calculations Mutat. Res. 453 2000 107 127
145. K. Sankaranarayanan R. Chakraborty Ionizing radiation and genetic risks. XII. The concept of ‘potential recoverability correction factor’ (PRCF) and its use for predicting the risk of radiation-inducible genetic disease in human live births Mutat. Res. 453 2000 129 181
146. K. Sankaranarayanan R. Chakraborty Ionizing radiation and genetic risks. XIII. Summary and synthesis of papers VI to XII and estimates of genetic risks in the year 2000 Mutat. Res. 453 2000 183 197
147. K. Sankaranarayanan R. Chakraborty E.A. Boerwinkle Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetic aspects of coronary heart disease, essential hypertension and diabetes mellitus Mutat. Res. 436 1999 21 57
148. K. Sankaranarayanan N. Yasuda R. Chakraborty Ionizing radiation and genetic risks. V. Multifactorial diseases: a review of epidemiological and genetic aspects of congenital abnormalities in man and of models on maintenance of quantitative traits in populations Mutat. Res. 317 1994 1 23
149. Searle, A.G., Beechey, C.V., 1986. The role of dominant visibles in mutagenicity testing. In: Ramel, C. et al. (Eds). Genetic Toxicology of Environmental Chemicals, Part B, Genetic Effects and Applied Mutagenesis. Alan R. Liss, New York, NY, 511–518.
150. P.B. Selby Discovery of numerous clusters of spontaneous mutations in the specific locus test in mice necessitates major increases in estimates of doubling doses Genetica 102/103 1998 463 487
151. P.B. Selby P.R. Selby Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice. I. Plan, summary of results and discussion Mutat. Res. 43 1977 357 375
152. UNSCEAR, 1972. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1972 Report to the General Assembly with Annexes, United Nations, New York.
153. UNSCEAR, 1977. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1977 Report to the General Assembly with Annexes, United Nations, New York.
154. UNSCEAR, 1988. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, Effects and Risks of Ionizing Radiation. 1988 Report to the General Assembly with Annexes, United Nations, New York.
155. UNSCEAR, 1993. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1993 Report to the General Assembly with Scientific Annexes, United Nations, New York.
156. UNSCEAR 2001. United Nations Scientific Committee on the Effects of Atomic Radiation. Heritable Effects of Radiation., 2001 Report to the General Assembly with Scientific Annex, United Nations, New York.
157. ICRP, 1991b. The 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1–3).
158. ICRP 1998a. Genetic susceptibility to cancer. ICRP Publication 79. Ann. ICRP 28 (1/2)
159. R). ICRP Publication 92. Ann. ICRP 33 (4)
160. ICRP, 2005d. Low-dose extrapolation of radiation-related cancer risk. ICRP Publication 99. Ann. ICRP 35 (4)
161. NAS/NRC, 2006. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Board on Radiation Effects Research. National Research Council of the National Academies, Washington, D.C.
162. NCRP, 2001. Evaluation of the Linear-Non-threshold Dose-Response Model for Ionizing Radiation. NCRP Report No. 36. National Council on Radiation Protection and Measurements, Bethesda, MD.
163. UNSCEAR, 1994. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. 1994 Report to the General Assembly with Scientific Annexes, United Nations, New York.
164. UNSCEAR, 2000. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. Vol. II Effects. 2000 Report to the General Assembly with Scientific Annexes, United Nations, New York.
165. UNSCEAR, 2001. United Nations Scientific Committee on the Effects of Atomic Radiation. Heritable Effects of Radiation., 2001 Report to the General Assembly with Scientific Annex, United Nations, New York.